Please use this identifier to cite or link to this item:
http://repository.kln.ac.lk/handle/123456789/12035
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kodisinghe, S.K. | - |
dc.contributor.author | Niriella, M.A. | - |
dc.date.accessioned | 2016-03-03T09:59:44Z | - |
dc.date.available | 2016-03-03T09:59:44Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Sri Lanka Journal of Diabetes Endocrinology and Metabolism.2015;5(1):28-33 | en_US |
dc.identifier.issn | 2012-998X | - |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/12035 | - |
dc.description.abstract | Non-alcoholic fatty liver disease (NAFLD)it is the commonest cause of chronic liver disease in developed countries and is rapidly increasing in the Asia-Pacific region. NAFLD has important long term health implications. There is increased overall mortality most commonly from cardiovascular disease, and also increased liver-related mortality. Treatment options available for NAFLD include general measures at managing obesity and correcting the metabolic syndrome and liver-directed therapies aimed at reducing the liver inflammation and hepatocellular injury. This article reviews the current evidence based management of NAFLD and associated metabolic comorbidities. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Endocrine Society of Sri Lanka | en_US |
dc.subject | non-alcoholic fatty liver disease | en_US |
dc.title | Evidence-based management of non-alcoholic fatty liver disease | en_US |
dc.type | Article | en_US |
Appears in Collections: | Journal/Magazine Articles |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.